Dow Up 1.18% Nasdaq Up 2.22%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NCM
1.48 Down 0.02(1.33%) 2:39PM EDT - Nasdaq Real Time Price
Prev Close:1.50
Open:1.50
Bid:1.47 x 8300
Ask:1.48 x 10400
1y Target Est:4.17
Beta:-0.31
Earnings Date:Dec 8 - Dec 12 (Est.)
Day's Range:1.42 - 1.51
52wk Range:1.16 - 3.18
Volume:776,500
Avg Vol (3m):1,090,470
Market Cap:265.67M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PPHM

Comparison

Symbol% ChgMkt Cap
PPHMDown 1.33%265.67M
AMGNUp 3.99%108.62B
NVSUp 0.66%214.67B
RHHBYUp 1.20%246.52B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-15) :-0.30
Quarterly EPS Est (Oct-14) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback